Live
FierceBiotechAstellas walks away from $1.6B biobucks T-cell engager pact with CytomX after 6 yearsFierceBiotechAmplifon to build vertical hearing aid player with €2.3B GN acquisitionFierceBiotechIdorsia shares sink after CEO's abrupt departureFierceBiotechDespite boosted funding, NIH still slow to award grants: analysisBioPharma DiveStructure’s GLP-1 pill shows ‘best-in-class’ potential in obesity trialBioWorldPrecision psychiatry beyond, or before, biomarkersBioWorldBiggest gainers and losers for March 9-13, 2026Endpoints NewsCytomX reports ADC data in late-line colorectal cancer; FDA OKs Cosentyx label expansionBioPharma DiveSarepta tests new Elevidys safeguards; Sana advances diabetes cell therapyEndpoints NewsNadia Care raises $12M to grow Medicaid maternal careBioWorldCD73-targeting immunoconjugates disclosed in Eisai patentBioWorldKyron-Servier deal focused on programmable glycoprotein platform
FierceBiotech Mar 16, 2026

Idorsia shares sink after CEO's abrupt departure

Idorsia shares sink after CEO's abrupt departure

Original
Body unavailable. Use the original source.

Directory

59 All